Latanoprost+timolol-Uk

Latanoprost and Timolol Maleate, the active ingredients in Latanoprost+timolol-Uk, are a prostaglandin analog and a non‑selective beta‑adrenergic blocker presented as an ophthalmic solution for ocular use. They lower intra‑ocular pressure in adults with primary open‑angle glaucoma or ocular hypertension, helping to preserve visual function and prevent disease progression.

GNH USA supplies Latanoprost+timolol-Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance, regulatory compliance, and reliable cold‑chain logistics where required, through robust quality systems.

Latanoprost/Timolol is used to manage ocular pressure in glaucoma and ocular hypertension. - Primary open‑angle glaucoma: reduces intra‑ocular pressure to slow optic nerve damage. - Ocular hypertension: lowers elevated eye pressure to prevent progression to glaucoma. - Pseudoexfoliative glaucoma: decreases intra‑ocular pressure in this secondary open‑angle condition.

Latanoprost/Timolol may cause ocular and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Eye irritation: transient burning or stinging after instillation. - Conjunctival hyperemia: mild redness of the eye. - Eyelash changes: increased length or thickness. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or difficulty breathing. - Persistent ocular inflammation: uveitis or keratitis. - Systemic bradycardia: markedly reduced heart rate. - Respiratory distress: bronchospasm in susceptible patients.

Before prescribing Latanoprost/Timolol, clinicians should consider several precautionary measures to ensure safe use. - Assess cardiac history: avoid in patients with severe bradycardia or heart block. - Evaluate respiratory status: caution in asthma or chronic obstructive pulmonary disease. - Monitor intra‑ocular pressure: check response after initiation and adjust therapy as needed. - Check for hypersensitivity: discontinue if allergic reaction occurs. - Avoid contact lens wear: discontinue drops at least 15 minutes before inserting lenses. - Store at room temperature: keep the ophthalmic solution below 25 °C, in the original container, protected from light and moisture.

Latanoprost/Timolol can interact with other medications, influencing its efficacy or safety.

Major Interactions (Avoid): - Non‑selective beta‑blockers (systemic): additive bradycardia and hypotension. - Sympathomimetic agents (e.g., epinephrine): may reduce ocular hypotensive effect. - MAO inhibitors: increased risk of hypertensive crisis when combined with topical adrenergic agents.

Moderate Interactions (Monitor Closely): - Carbonic anhydrase inhibitors: enhanced intra‑ocular pressure lowering, monitor for over‑reduction. - Anticholinergic eye drops: may affect pupil size and ocular comfort. - Systemic steroids: may diminish prostaglandin efficacy, watch pressure control.